Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Top Liposomal Bupivacaine Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Liposomal Bupivacaine Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 20ml
1.3.3 10ml
1.4 Market Segment by Application
1.4.1 Global Liposomal Bupivacaine Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Veterinary
1.4.3 Human
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Liposomal Bupivacaine Revenue (2015-2026)
2.1.1 Global Liposomal Bupivacaine Revenue (2015-2026)
2.1.2 Global Liposomal Bupivacaine Sales (2015-2026)
2.2 Liposomal Bupivacaine Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Liposomal Bupivacaine Sales by Regions (2015-2020)
2.2.2 Global Liposomal Bupivacaine Revenue by Regions (2015-2020)
2.3 Global Top Liposomal Bupivacaine Regions (Countries) Ranking by Market Size
2.4 Liposomal Bupivacaine Industry Trends
2.4.1 Liposomal Bupivacaine Market Top Trends
2.4.2 Market Drivers
2.4.3 Liposomal Bupivacaine Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Liposomal Bupivacaine Players: Views for Future
3 Competitive Landscape by Manufacturers
3.1 Global Top Liposomal Bupivacaine Manufacturers by Sales (2015-2020)
3.1.1 Global Liposomal Bupivacaine Sales by Manufacturers (2015-2020)
3.1.2 Global Liposomal Bupivacaine Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Liposomal Bupivacaine Sales in 2019
3.2 Global Top Manufacturers Liposomal Bupivacaine by Revenue
3.2.1 Global Liposomal Bupivacaine Revenue by Manufacturers (2015-2020)
3.2.2 Global Liposomal Bupivacaine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Liposomal Bupivacaine Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liposomal Bupivacaine as of 2019)
3.4 Global Liposomal Bupivacaine Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Liposomal Bupivacaine Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Liposomal Bupivacaine Market
3.7 Key Manufacturers Liposomal Bupivacaine Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Liposomal Bupivacaine Historic Market Review by Type (2015-2020)
4.1.2 Global Liposomal Bupivacaine Sales Market Share by Type (2015-2020)
4.1.3 Global Liposomal Bupivacaine Revenue Market Share by Type (2015-2020)
4.1.4 Liposomal Bupivacaine Price by Type (2015-2020)
4.1 Global Liposomal Bupivacaine Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Liposomal Bupivacaine Sales Forecast by Type (2021-2026)
4.2.3 Global Liposomal Bupivacaine Revenue Forecast by Type (2021-2026)
4.2.4 Liposomal Bupivacaine Price Forecast by Type (2021-2026)
5 Global Liposomal Bupivacaine Market Size by Application
5.1 Global Liposomal Bupivacaine Historic Market Review by Application (2015-2020)
5.1.2 Global Liposomal Bupivacaine Sales Market Share by Application (2015-2020)
5.1.3 Global Liposomal Bupivacaine Revenue Market Share by Application (2015-2020)
5.1.4 Liposomal Bupivacaine Price by Application (2015-2020)
5.2 Global Liposomal Bupivacaine Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Liposomal Bupivacaine Sales Forecast by Application (2021-2026)
5.2.3 Global Liposomal Bupivacaine Revenue Forecast by Application (2021-2026)
5.2.4 Liposomal Bupivacaine Price Forecast by Application (2021-2026)
6 North America
6.1 North America Liposomal Bupivacaine Breakdown Data by Company
6.2 North America Liposomal Bupivacaine Breakdown Data by Type
6.3 North America Liposomal Bupivacaine Breakdown Data by Application
6.4 North America Liposomal Bupivacaine Breakdown Data by Countries
6.4.1 North America Liposomal Bupivacaine Sales by Countries
6.4.2 North America Liposomal Bupivacaine Revenue by Countries
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Liposomal Bupivacaine Breakdown Data by Company
7.2 Europe Liposomal Bupivacaine Breakdown Data by Type
7.3 Europe Liposomal Bupivacaine Breakdown Data by Application
7.4 Europe Liposomal Bupivacaine Breakdown Data by Countries
7.4.1 Europe Liposomal Bupivacaine Sales by Countries
7.4.2 Europe Liposomal Bupivacaine Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Liposomal Bupivacaine Breakdown Data by Company
8.2 Asia Pacific Liposomal Bupivacaine Breakdown Data by Type
8.3 Asia Pacific Liposomal Bupivacaine Breakdown Data by Application
8.4 Asia Pacific Liposomal Bupivacaine Breakdown Data by Regions
8.4.1 Asia Pacific Liposomal Bupivacaine Sales by Regions
8.4.2 Asia Pacific Liposomal Bupivacaine Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Liposomal Bupivacaine Breakdown Data by Company
9.2 Latin America Liposomal Bupivacaine Breakdown Data by Type
9.3 Latin America Liposomal Bupivacaine Breakdown Data by Application
9.4 Latin America Liposomal Bupivacaine Breakdown Data by Countries
9.4.1 Latin America Liposomal Bupivacaine Sales by Countries
9.4.2 Latin America Liposomal Bupivacaine Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Liposomal Bupivacaine Breakdown Data by Type
10.2 Middle East and Africa Liposomal Bupivacaine Breakdown Data by Application
10.3 Middle East and Africa Liposomal Bupivacaine Breakdown Data by Countries
10.3.1 Middle East and Africa Liposomal Bupivacaine Sales by Countries
10.3.2 Middle East and Africa Liposomal Bupivacaine Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E
11 Company Profiles
11.1 Pacira Pharmaceuticals
11.1.1 Pacira Pharmaceuticals Corporation Information
11.1.2 Pacira Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Pacira Pharmaceuticals Liposomal Bupivacaine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Pacira Pharmaceuticals Liposomal Bupivacaine Products and Services
11.1.5 Pacira Pharmaceuticals SWOT Analysis
11.1.6 Pacira Pharmaceuticals Recent Developments
12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Liposomal Bupivacaine Sales Channels
12.2.2 Liposomal Bupivacaine Distributors
12.3 Liposomal Bupivacaine Customers
13 Estimates and Projections by Regions (2021-2026)
13.1 Global Liposomal Bupivacaine Sales Forecast (2021-2026)
13.1.1 Global Liposomal Bupivacaine Sales Forecast by Regions (2021-2026)
13.1.2 Global Liposomal Bupivacaine Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Liposomal Bupivacaine Sales Forecast (2021-2026)
13.2.2 North America Liposomal Bupivacaine Revenue Forecast (2021-2026)
13.2.3 North America Liposomal Bupivacaine Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Liposomal Bupivacaine Sales Forecast (2021-2026)
13.3.2 Europe Liposomal Bupivacaine Revenue Forecast (2021-2026)
13.3.3 Europe Liposomal Bupivacaine Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Liposomal Bupivacaine Sales Forecast (2021-2026)
13.4.2 Asia Pacific Liposomal Bupivacaine Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Liposomal Bupivacaine Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Liposomal Bupivacaine Sales Forecast (2021-2026)
13.5.2 Latin America Liposomal Bupivacaine Revenue Forecast (2021-2026)
13.5.3 Latin America Liposomal Bupivacaine Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Liposomal Bupivacaine Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Liposomal Bupivacaine Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Liposomal Bupivacaine Size Forecast by County (2021-2026)
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
【掲載企業】
Pacira Pharmaceuticals
【免責事項】
https://www.globalresearch.jp/disclaimer